HUMAN-IGM MONOCLONAL-ANTIBODY 16.88 - PHARMACOKINETICS AND DISTRIBUTION IN MOUSE AND MAN

被引：0
|
作者：
HAISMA, HJ
KESSEL, MAP
SILVA, C
VANMUIJEN, M
ROOS, JC
BRIL, H
MARTENS, HJM
MCCABE, R
BOVEN, E
机构：
[1] BIONET RES INST,ROCKVILLE,MD 20850
[2] FREE UNIV AMSTERDAM HOSP,DEPT NUCL MED,1081 HV AMSTERDAM,NETHERLANDS
[3] FREE UNIV AMSTERDAM HOSP,DEPT PATHOL,1081 HV AMSTERDAM,NETHERLANDS
[4] FREE UNIV AMSTERDAM HOSP,DEPT PHARM,1081 HV AMSTERDAM,NETHERLANDS
来源：
BRITISH JOURNAL OF CANCER | 1990年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：40 / 43
页数：4
相关论文
共 50 条
  • [1] HUMAN-IGM MONOCLONAL ANTIBODY-16.88 - PHARMACOKINETICS AND IMMUNOGENICITY IN COLORECTAL-CANCER PATIENTS
    HAISMA, HJ
    PINEDO, HM
    KESSEL, MAP
    VANMUIJEN, M
    ROOS, JC
    PLAIZIER, MABD
    MARTENS, HJM
    DEJAGER, R
    BOVEN, E
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (24) : 1813 - 1819
  • [2] THE STABILIZATION OF A HUMAN-IGM MONOCLONAL-ANTIBODY WITH POLY(VINYLPYRROLIDONE)
    GOMBOTZ, WR
    PANKEY, SC
    PHAN, D
    DRAGER, R
    DONALDSON, K
    ANTONSEN, KP
    HOFFMAN, AS
    RAFF, HV
    PHARMACEUTICAL RESEARCH, 1994, 11 (05) : 624 - 632
  • [3] PHASE-I TRIAL AND PHARMACOKINETICS OF A HUMAN-IGM MONOCLONAL-ANTIBODY TO ENDOTOXIN (LPS)
    KHAZAELI, M
    KUBAGAWA, H
    TENG, N
    ZIEGLER, E
    ROGERS, K
    PETERSON, L
    SALEH, M
    BOGARD, C
    CARRANO, R
    BERGER, H
    LOBUGLIO, A
    CLINICAL RESEARCH, 1987, 35 (03): : A615 - A615
  • [4] TUMOR-LOCALIZATION WITH I-131-LABELED HUMAN-IGM MONOCLONAL-ANTIBODY 16.88 IN ADVANCED COLORECTAL-CANCER PATIENTS
    BOVEN, E
    HAISMA, HJ
    BRIL, H
    MARTENS, HJM
    VANLINGEN, A
    DENHOLLANDER, W
    KESSEL, MAP
    DEJAGER, RL
    ROOS, JC
    EUROPEAN JOURNAL OF CANCER, 1991, 27 (11) : 1430 - 1436
  • [5] TREATMENT OF EXPERIMENTAL PSEUDOMONAS-AERUGINOSA PNEUMONIA WITH A HUMAN-IGM MONOCLONAL-ANTIBODY
    HECTOR, RF
    COLLINS, MS
    PENNINGTON, JE
    JOURNAL OF INFECTIOUS DISEASES, 1989, 160 (03): : 483 - 489
  • [6] EVALUATION OF PRODUCT EQUIVALENCE DURING PROCESS OPTIMIZATION FOR MANUFACTURE OF A HUMAN-IGM MONOCLONAL-ANTIBODY
    MAIORELLA, BL
    FERRIS, R
    THOMSON, J
    WHITE, C
    BRANNON, M
    HORA, M
    HENRIKSSON, T
    TRIGLIA, R
    KUNITANI, M
    KRESIN, L
    DOLLINGER, G
    JONES, R
    SENYK, G
    YOUNG, J
    MOYER, B
    MCENTIRE, J
    DOUGHERTY, J
    MONICA, T
    GOOCHEE, C
    BIOLOGICALS, 1993, 21 (03) : 197 - 205
  • [7] PHARMACOKINETICS OF IGM MONOCLONAL-ANTIBODY DELIVERY TO NORMAL BRAIN
    NEUWELT, E
    BARNETT, P
    MCCORMICK, C
    MINNA, J
    FRENKEL, E
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 295 - 295
  • [8] A MOUSE MONOCLONAL-ANTIBODY REACTIVE PREFERENTIALLY WITH HUMAN IGM-LAMBDA
    OHNO, T
    COOPER, MD
    KUBAGAWA, H
    HYBRIDOMA, 1990, 9 (05): : 473 - 480
  • [9] QUANTIFICATION OF MONOCLONAL HUMAN-IGM
    KLEIN, F
    DEBRUIJN, AM
    KORNMANVANDENBOSCH, HJ
    CLINICAL CHEMISTRY, 1985, 31 (02) : 353 - 353
  • [10] PHARMACOKINETICS OF AN IGM HUMAN MONOCLONAL-ANTIBODY AGAINST PSEUDOMONAS-AERUGINOSA IN NONSEPTIC PATIENTS
    MENG, YG
    WONG, T
    SARAVOLATZ, LD
    PENNINGTON, JE
    JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (03): : 784 - 785
12345